insights_auto
Why is CSBR down 2,21%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
4,49 USD
arrow_downward
-2,21%(-0,10) 1D
18-ноя., 10:42:24 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,55 USD
High
4,60 USD
Low
4,49 USD
Mkt. cap
62,52 млн
Avg. vol.
7,41 миң
Volume
3,47 миң
52-wk high
8,31 USD
52-wk low
4,49 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
Open
4,55 USD
High
4,60 USD
Low
4,49 USD
Mkt. cap
62,52 млн
Avg. vol.
7,41 миң
Volume
3,47 миң
52-wk high
8,31 USD
52-wk low
4,49 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
News stories
From web sources and news partners
TradingView
·
2 саат мурун
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Mixed Ahead of FOMC Minutes— NVDA, AAOI, PANW in Focus (UPDATED)
San Luis Obispo Tribune
·
1 саат мурун
S&P 500, Nasdaq open higher as Nvidia forecast eases AI jitters
CNBC
·
41 мүнөт мурун
The key S&P 500 level Wall Street is watching
FOREX.com
·
4 саат мурун
S&P 500 Quietly Shrugs Off the Bitcoin and Silver Selloff
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersХаккенсак, Нью Джерси, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitechampionsoncology.com